Active Shortage

IBSRELA

KNIGHT THERAPEUTICS INC.

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of IBSRELA in Canada?

Yes. IBSRELA 50MG has an active shortage reported to Health Canada (last updated October 27, 2026).

When will IBSRELA be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Check with your pharmacist

StatusActive Shortage

Same-ingredient products on fileNone found

Affected strength50MG

Report last updated2026-10-27

Checked by MedShort2026-11-13

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02498049

Strength

50MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

TENAPANOR

Tier

Unrated

Last Updated

2026-10-27

Reason for Shortage

Other (Please describe in comments)

Source

View original report on healthproductshortages.ca ↗

Other Products from KNIGHT THERAPEUTICS INC.

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

AKYNZEO

DIN 02468735

ALOXI

0.5MG · DIN 02381729

ALOXI

0.25MG · DIN 02381710

ANACIN

DIN 02332450

ANTIZOL

1G · DIN 02242980

BIJUVA

DIN 02505223